» Authors » Peter Knoflach

Peter Knoflach

Explore the profile of Peter Knoflach including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 287
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofer H, Willheim-Polli C, Knoflach P, Gabriel C, Vogel W, Trauner M, et al.
J Hum Genet . 2021 Jun; 66(12):1199. PMID: 34131283
No abstract available.
2.
Dolak W, Schwaighofer H, Hellmich B, Stadler B, Spaun G, Plieschnegger W, et al.
United European Gastroenterol J . 2017 Apr; 5(1):104-110. PMID: 28405328
Background: Photodynamic therapy (PDT) is a palliative treatment for malignant biliary obstruction. Objective: The objective of this article is to assess the feasibility and safety of this technique. Methods: In...
3.
Ferlitsch M, Heinze G, Salzl P, Britto-Arias M, Waldmann E, Reinhart K, et al.
Med Oncol . 2014 Aug; 31(9):151. PMID: 25115743
Due to high costs and limited availability of screening colonoscopy, some screening programs require a positive fecal occult blood test (FOBT) before screening colonoscopy is remunerated. As male sex is...
4.
Bannert C, Reinhart K, Dunkler D, Trauner M, Renner F, Knoflach P, et al.
Am J Gastroenterol . 2012 Nov; 107(12):1837-48. PMID: 23147522
Objectives: Quality indicators including cecal intubation rate (CIR) and adenoma detection rate (ADR) are established. Sex differences of quality indicators are observed, but the influence of sedation has not been...
5.
Papay P, Miehsler W, Tilg H, Petritsch W, Reinisch W, Mayer A, et al.
J Crohns Colitis . 2012 Nov; 7(9):723-9. PMID: 23127785
Background And Aims: Patients with inflammatory bowel disease (IBD) are at increased risk of venous thromboembolism (VTE), but data on frequency, site of thrombosis and risk factors are limited. We...
6.
Kapral C, Muhlberger A, Wewalka F, Duller C, Knoflach P, Schreiber F
Eur J Gastroenterol Hepatol . 2012 Nov; 24(12):1447-54. PMID: 23114747
Objective: Endoscopic retrograde cholangiopancreatography (ERCP) has a high risk of various complications. The aim of this study is to report the main ERCP outcome, that means complications and success rates,...
7.
Hofer H, Willheim-Polli C, Knoflach P, Gabriel C, Vogel W, Trauner M, et al.
J Hum Genet . 2012 Jul; 57(9):564-7. PMID: 22763723
Wilson disease (WD), a disorder of copper metabolism is caused by mutations in the ATP7B gene, a copper transporting ATPase. In the present study we describe a novel mutation in...
8.
9.
Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, et al.
Gastroenterology . 2010 Jun; 139(3):779-87, 787.e1. PMID: 20546736
Background & Aims: Patients with inflammatory bowel disease (IBD) are at increased risk of a first venous thromboembolism (VTE), yet their risk of recurrent VTE is unknown. We performed a...
10.
Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, et al.
Eur J Gastroenterol Hepatol . 2009 May; 22(3):306-10. PMID: 19474748
Background And Aims: Germline mutations in the E-cadherin (CDH1) gene have been found in families with hereditary diffuse gastric cancer (HDGC). These families are characterized by a highly penetrant susceptibility...